Physician

Sonal Paul

According to 2025 Medicare claims, Sonal Paul (NPI: 1922452077) practices hematology/oncology in the Washington, DC-MD market, with the plurality of this provider's patient population coming from The District, DC. This provider's primary affiliated billing organization is MEDICAL FACULTY ASSOCIATES, INC (NPI: 1417990581; TIN: 522220700) and primary practice location at 20037-3201. Paul is affiliated with the PBACO Holding, LLC (ACO ID: A1001), participating under the MSSP model.

Paul's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 173 traditional Medicare patients, billed 12,766 HCPCS/CPT codes, and received $237,632 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 307 prescription claims across 87 beneficiaries totaling $1,005,486 in drug costs, led by Tasigna (Nilotinib Hcl). Open Payments data shows 11 records totaling $18,692. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $18,498 to $1,005,486. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$119K$238K2022 Medicare payment: $16,445 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $65,740 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $237,632 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202288148$16,445
2023243561$65,740
202417312,766$237,632

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$512K$1.0M2016 Drug cost: $18,498 (USD; Tot_Drug_Cst)2017 Drug cost: $51,749 (USD; Tot_Drug_Cst)2018 Drug cost: $115,437 (USD; Tot_Drug_Cst)2019 Drug cost: $102,865 (USD; Tot_Drug_Cst)2020 Drug cost: $29,278 (USD; Tot_Drug_Cst)2021 Drug cost: $168,489 (USD; Tot_Drug_Cst)2022 Drug cost: $176,615 (USD; Tot_Drug_Cst)2023 Drug cost: $1,024,675 (USD; Tot_Drug_Cst)2024 Drug cost: $1,005,486 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
201646231$18,498
201797591$51,749
2018104828$115,437
201967285$102,865
20201541$29,278
20211342$168,489
20223389$176,615
202365398$1,024,675
202487307$1,005,486

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more3737$171
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more58116$135
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes2526$102
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more6780$101
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's4173$14

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TasignaNilotinib Hcl12336$236,647
EliquisApixaban331,290$25,073
XareltoRivaroxaban21801$15,411
Tamoxifen CitrateTamoxifen Citrate12351$1,032
AcyclovirAcyclovir12540$500

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$1,844AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.3$16,848GlaxoSmithKline, LLC.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sonal Paul?

Tedicare shows public-source Medicare data for Sonal Paul (NPI 1922452077), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sonal Paul have ACO affiliation data?

Sonal Paul is shown with ACO affiliation data for PBACO Holding, LLC (MSSP, ACO ID A1001).

What billing organization is linked to Sonal Paul?

Sonal Paul is linked to MEDICAL FACULTY ASSOCIATES, INC (billing NPI 1417990581) in the available physician profile data.

Does Sonal Paul have Open Payments data?

Sonal Paul has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.